Related Experiment Videos

Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit

I Schuller1, V Saha, L Lin

  • 1Department of Paediatric Oncology, St Bartholomew's Hospital, London.

Insights

Clostridium difficile infection (CDI) in pediatric cancer patients is a concern. This study found infection determinants were hospital stay and diagnosis, not age, with lymphoid malignancies at highest risk.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Epidemiology

Background:

  • Limited data exists on Clostridium difficile infection (CDI) in pediatric cancer patients.
  • Previous reports suggested a high carriage rate and morbidity, particularly in younger children.
  • A presumed outbreak prompted further investigation into CDI prevalence in this vulnerable population.

Purpose of the Study:

  • To monitor the prevalence of Clostridium difficile infection on a pediatric oncology ward.
  • To identify risk factors and determinants for CDI in children undergoing cancer treatment.
  • To investigate the origin and characteristics of CDI during the study period.

Main Methods:

  • Prospective surveillance of CDI in 214 children on a pediatric oncology ward from June 1991 to May 1992.
  • Polyacrylamide gel electrophoresis (PAGE) used to characterize C. difficile strains.
  • Analysis of patient data to determine factors associated with infection, including age, diagnosis, treatment intensity, neutropenia, and antibiotic exposure.

Main Results:

  • Twenty-eight (13%) of 214 children were infected with C. difficile.
  • Strain typing revealed multiple C. difficile types, suggesting endogenous or environmental origins rather than cross-infection.
  • Infection was not associated with age; however, duration of hospital stay and primary diagnosis (lymphoid malignancies highest risk) were significant determinants. Intensive treatment, neutropenia, and prolonged antibiotic use were associated with highest risk.

Conclusions:

  • CDI in pediatric oncology patients is influenced by treatment intensity and duration of hospital stay, not age.
  • Lymphoid malignancies and intensive treatment protocols requiring prolonged neutropenia and antibiotics confer the highest risk.
  • Prompt identification and control measures are crucial; diarrhea in these patients should always be investigated.

Related Concept Videos